Posts

Showing posts from June, 2018

New Therapy Benefits Patients with Neuroendocrine Tumors

NCTN/NCORP Data Archive: Expanding Access to Clinical Trial Data

Three-Drug Combination Extends Survival for Patients with Multiple Myeloma

NExT: Advancing Promising Cancer Therapies from the Lab to Clinical Trials

Combination Therapy Improves Survival for Some Men with Recurrent Prostate Cancer

Professor Johann de Bono to chair NCRI Cancer Conference

Potential New Cancer Therapy Could Target Tumors Two Ways

Hiking with an Ostomy? Don’t let it slow you down

Altering Chemotherapy Improves Outcomes in Early-Stage Pancreatic Cancer

U.S. Cancer Mortality Rates Falling, But Some Regions Left Behind, Study Finds

Immunotherapy drug for skin disease could boost hormone treatment for prostate cancer

Cancer Moonshot Moves Forward, Bringing Funding Opportunities for Researchers

Faces of Blue: Genie Davis

Conditional Reprogramming: An Interview with Dr. Richard Schlegel on Growing Cancer Cells

Outsmarting cancer – staying one step ahead of drug resistance

Lung Cancer Screening Pilot Reveals Challenges, Growing Pains

Bowel cancer study reveals impact of mutations on protein networks

ICR and partners take centre stage at major international conferences

Research Advocates at ASCO 18: Insight from the ground

New on NCI Websites for June 2018

FDA Approves Nivolumab for Bladder Cancer

SCOTTISH GOVERNMENT ANNOUNCE FUNDING TO TACKLE LONG WAITING TIMES FOR BOWEL CANCER TESTS

Professor Mel Greaves awarded prestigious Society of Memorial Sloan Kettering Prize for contributions to childhood cancer

Study Shows Platelets Can Deliver Immunotherapy, Reduce Tumor Regrowth

The ICR responds to Sir John Bell's Life Sciences Industrial Strategy

New on NCI Websites for March 2017

Approval Expanded for Venetoclax in Chronic Lymphocytic Leukemia

The Life Sciences Industrial Strategy – what does it mean for cancer research?

Exploration and exploitation of potential drug space using computers

America approves ‘revolutionary’ CAR T cell immunotherapy — what does this mean for cancer patients?

Putting the Cancer Patient Front and Center: An Interview with NCI’s Dr. Paul Jacobsen

FDA Approves New Use for Lenalidomide in Multiple Myeloma

Researchers Use CRISPR Gene-Editing Tool to Help Turn Immune Cells against Tumors

Fight CRC Welcomes New Board Members

Higher BMI is associated with a lower risk of breast cancer before the menopause

Do Frequent Follow-Up Tests Benefit Colorectal Cancer Survivors?

Fight CRC’s Julienne Gede Edwards awarded 2018 Critical Mass Young Adult Cancer Advocacy Hero Award

Harvesting the Journey: Embrace, Empower, Endure

Defeating childhood cancer – fighting on multiple fronts

New approach could better predict breast cancer risk due to family history

Stem-Cell Based Tool May Help Measure Heart Toxicity of Cancer Drugs

ICR responds to Government’s policy paper on science and innovation after Brexit

Precision Medicine Forges Ahead with New Data from the NCI-MATCH Trial

June 2018 Recipe

Biosimilars for Cancer Emerge as Patents on Widely Used Biological Drugs Expire

ASCO 18: Research updates and Fight Colorectal Cancer’s role

New software can correct systematic 'batch effects' error in research data

The secrets of successful industry-academic partnerships

Science after Brexit – how will we continue to collaborate with the EU on medical research?

How our research is making radiotherapy smarter and kinder for cancer patients

rss

Colorectal Cancer Incidence Rising in Young Adults: An Interview with Drs. Philip Rosenberg and William Anderson

Why developing treatments into rare childhood cancers is a team effort

Exploring the future of genomics – the potential of sequencing technologies like NovaSeq

The ICR pays tribute to researcher James Morden

Targeted Cancer Drug May Also Help Protect Fertility, Study Suggests

Testing metabolites in blood predicts success of skin cancer treatment

Whole-body scans benefit people with highest inherited cancer risk

Blinatumomab Extends Survival for Patients with Advanced ALL

ICR ranked among the world’s best research institutions for industry collaboration

Trial Produces Practice-Changing Findings for Some Children, Young Adults with Leukemia

ICR reacts to decision to make the immunotherapy nivolumab available on the Cancer Drugs Fund for non-small cell lung cancers

Gene testing could identify men with prostate cancer who may benefit from immunotherapy

Blood test could predict response of HPV-positive head and neck cancer to treatment

New treatment approach for rare type of ‘triple negative’ breast cancers identified

Blocking energy production could help treat lung cancer where chemotherapy has limited effect

Hiking for the first time? Bring a buddy!